COMP <GO>
RCEL vs SSII // 10Y YIELD & FRED MACRO BETA
Avita Medical Inc. (NASDAQ) VS. SS Innovations International Inc. (NASDAQ) • 15-METRIC TALLY: RCEL 3
— SSII 5
■ METRIC PARITY
LAST: $15.41 (-1.53%) • MKT CAP: $484.0M
macro-sensitivity
—
LAST: $2.31 (-1.70%) • MKT CAP: $471.1M
macro-sensitivity
—
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (RCEL VS. SSII)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | RCEL | SSII | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 82.10% | 46.00% | +36.10 | RCEL | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -35.00% | -18.50% | -16.50 | SSII | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | -6.23% | -4.65% | -1.58 | SSII | /fcf-yield <GO> |
| Operating Margin | -59.40% | -19.30% | -40.10 | SSII | /operating-margins <GO> |
| Net Profit Margin | -60.00% | -28.50% | -31.50 | SSII | /net-margins <GO> |
| Revenue Growth (YoY) | 11.50% | 105.70% | -94.20 | SSII | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | — | 7.47 | — | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality | 4/9 | 4/9 | 0.00 | TIE | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 61.1 | 36.6 | +24.50 | RCEL | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta ACTIVE | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | — | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $484.0M | $471.1M | $12.9M | RCEL | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | RCEL REV | SSII REV | RCEL GROSS % | SSII GROSS % | RCEL FCF | SSII FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $71.6M | $42.5M | 82.1% | 46.0% | -$32.2M | -$22.2M |
| FY 2024 | $64.3M | $20.6M | 85.8% | 40.9% | -$58.1M | -$10.2M |
| FY 2023 | $50.1M | $5.9M | — | — | -$38.0M | -$15.4M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
RCEL // BETA —
SSII // BETA —